Veterinary Medicines

Febrivac DE Vet. pulver og solvens til injektionsvæske, suspension

Authorised
  • Mink enteritis virus, strain E-MINK F1, Inactivated
  • Canine distemper virus, strain Lederle D84/1, Live
Download as PDF

Product identification

Medicine name:
Febrivac DE Vet. pulver og solvens til injektionsvæske, suspension
Febrivac DE Vet. pulver og solvens til injektionsvæske, suspension
Active substance:
  • Mink enteritis virus, strain E-MINK F1, Inactivated
  • Canine distemper virus, strain Lederle D84/1, Live
Target species:
  • Fur animals
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mink enteritis virus, strain E-MINK F1, Inactivated
    10000.00
    tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain Lederle D84/1, Live
    5012.00
    tissue culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Fur animals
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CH01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 15553
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, PULVER OG SOLVENS TIL INJEKTIONSVÆSKE, SUSPENSION)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."